An overview of the rationale for pharmacological strategies in type 2 diabetes: from the evidence to new perspectives
Louis Monnier(Université de Montpellier), C Colette(Université de Montpellier), S Charra-Ebrard(Hôpital Lapeyronie), Catherine Boegner(Institute of Clinical Research), M. Bénichou(Hôpital Lapeyronie)
Cited by 70
Related Papers
Contributions of Fasting and Postprandial Plasma Glucose Increments to the Overall Diurnal Hyperglycemia of Type 2 Diabetic Patients
|Diabetes Care|2003|1.5k
The Loss of Postprandial Glycemic Control Precedes Stepwise Deterioration of Fasting With Worsening Diabetes
|Diabetes Care|2007|494
Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes
|Diabetes Care|2016|382
Glycemic Variability: The Third Component of the Dysglycemia in Diabetes. Is it Important? How to Measure it?
|Journal of Diabetes Science and Technology|2008|287